Meetings/Workshops on Neurology in the United States (USA)

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events.
Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

Welcome to the Neuromodulation Symposium organized by the Institute for Engineering in Medicine. Neuromodulation is a rapidly-growing field, encompassing a wide spectrum of implantable and non-invasive technology-based approaches for the treatment of neurological and psychiatric disorders. Advancing the field of neuromodulation represents challenges to developing engineering methodologies, understanding mechanisms of neuromodulation at cellular and systems levels, clinical application to treat patients, as well as regulatory process. This symposium is aimed at bringing together basic scientists, engineers, clinicians, industrial practitioners and entrepreneurs to discuss challenges and opportunities in neuromodulation. The symposium will consist of plenary presentations by leaders in academia, industry and government, and poster presentations to exchange ideas in this exciting field. The Symposium will be held immediately following the Design of Medical Devices Conference.

Neurotrophic factors play essential roles in the developing and mature nervous system. While Nerve growth factor (NGF) was the first neurotrophic factor when it was identified more than 50 years ago, a large set of related and unrelated extracellular proteins are now known to exert neurotrophic effects in the developing and mature nervous system. The roles of neurotrophic factors include regulation of cell proliferation, survival, differentiation, migration, axon and dendrite growth, synaptic plasticity and the interactions of neuronal and glial cells. As a result, neurotrophic factors affect complex behaviors including feeding, anxiety, depression and learning, and aberrations in the activities of neurotrophic factors have been implicated in multiple neurologic and psychiatric disorders. The Neurotrophic Factors Gordon Conference provides a great opportunity to learn of recent advances in this broad field, and enhances collaborations among scientists and students. The meeting will feature work on diverse neurotrophic factors and their roles in neurogenesis, neuronal migration, survival, plasticity, behavior and diseases, including disorders of neural development such as autism and epilepsy and degenerative disorders such as Alzheimer's disease and peripheral neuropathies. Emphasis will be placed on the most recent developments.

Perhaps no other structure is more fundamental to our understanding of the brain than the synapse. In the central nervous system, excitatory synapses represent the primary source of information communication between neurons, whether for local interactions within circuits or for linking discrete regions of the brain. One of the most extraordinary properties of excitatory synapses is the ability to under activity-dependent long-lasting changes in synaptic strength, providing the most compelling cellular model for learning and memory. Synapses also serve as the site of action for many commonly prescribed medications and synaptic disruption contributes to many neurological and psychiatric disorders. These include schizophrenia, autism, depression, substance abuse and addiction, Parkinson’s disease, Alzheimer’s disease, traumatic brain injury, stroke and epilepsy. In some cases, synaptic dysfunction is causal in disease, whereas in other cases it represents the downstream sequelae of one or more underlying molecular defects. In either case, a fundamental understanding of the formation, structure, molecular organization, signaling function, and plasticity of synapses is essential to achieving progress in lessening the burden of human neurological disease and for predicting and improving mental health.

Our keynote speaker is Dr. Brenda Banwell, Chief of Neurology at the Children’s Hospital of Philadelphia. She will talk about pediatric multiple sclerosis including her groundbreaking work. She will also do a ‘meet the speaker’ session in the afternoon. Dr. Ian Rossman and Dr. Manikum Moodley will do case presentations in pediatric MS and
related disorders to round out our pediatric MS theme.

5.Gordon Research Conference — Parkinson's Disease: Emerging Research in the Etiology and Pathogenesis of a Complex Disease 2015

Dates

28 Jun 2015 → 03 Jul 2015

[ID=655662]

Location

New London, United States

Abstract

Parkinson’s disease (PD) is the most common motor disorder. Over the past fifteen years, the discovery of disease-causing mutations in a growing number of genes has accelerated the pace of our understanding of disease mechanisms. Simultaneous discoveries in cell biology and immunological processes are rapidly providing insights into the processes that lead to this disease. This creates an exciting series of challenges and opportunities to be addressed by discussion and exchange of ideas. There has to our knowledge never been a basic research conference devoted to Parkinson’s, and this conference will bring together investigators with diverse scientific backgrounds who share an interest in the cellular mechanisms that produce PD and its related disorders. The specific content of the Conference will evolve as our understanding of PD evolves. For the first Conference, topics will include: The normal function of PD-related genes; The cellular response to toxic protein aggregates; Endoplasmic reticulum stress; Proteasomal and autophagic processes; Neuroimmune pathways; and Prion-like aggregate pathogenesis.

Neurological Disorders Summit-2015 is designed to bring together the scientific community - principal investigators, scientists, researchers, health professionals, analysts, clinicians, policy makers, industry experts, the well established and the budding entrepreneurs to discuss the present and future perspectives entailing progress, challenges in neurological disorders therapeutics.

Neural crest cells and cranial sensory placodes are of central importance to the development and evolution of vertebrates, and are also of high clinical significance. This conference is designed to facilitate shared insights among attendees and fuel further advances in our understanding of the mechanisms governing the formation, behavior and differentiation of these two cell populations, as well as to catalyze the application of this knowledge to the field of regenerative medicine. The central goals of the conference are to accelerate the exchange of information across different model systems, to promote technological innovations in the field, and to further a genome and proteome scale understanding of the mechanisms that govern the development of neural crest cells and cranial sensory placodes. Both neural crest cells and cranial placode cells make extensive contributions to embryonic structures, and defects in their development underlie a broad range of congenital disorders. Neural crest cells display stem cell attributes, and neural crest-derived cells persist as stem cells into adulthood; studies of these cells provide broad insights into stem cell biology. Moreover, neural crest cells undergo migratory and invasive behavior driven by core EMT regulatory factors, and understanding how their behavior is regulated provides insights into the related invasive behavior of metastatic tumor cells. Cranial placode cells play important roles in the development of cranial sensory structures; mutations in genes that regulate their development lead to human syndromes with severe sensory deficits and dysregulated cell cycle control in numerous cancers. The conference will bring together a diverse group of scientists in a collegial atmosphere that fosters substantive discussions and promotes collaborative interactions between basic and clinical scientists in this important area of biomedical research.

The amygdala, a temporal lobe structure that forms part of the limbic system, plays a key role in emotional processing. Its relevance to fear and anxiety in animals has been well known since the classic experiments of Kluver and Bucy, who made mid-temporal lesions in monkeys and found profound effects on the emotional and social behaviour of these animals. Focus on studies of the amygdala expanded greatly when its role in fear conditioning was established. Fear conditioning is a simple Pavlovian conditioning task in which a neutral stimulus is contingently paired with an aversive stimulus. The simple nature of this learning task, and the readily measured physiological changes that accompany it, have made the study of fear conditioning a very attractive target for the study of learning and memory consolidation. As the neural circuitry that underlies fear conditioning is simple and appears to be preserved between species, it presents an accessible model for the study of learning and memory formation in the mammalian nervous system. Because of the physiological similarities between animal and human fear, fear conditioning is seen as relevant to the genesis of anxiety disorders in humans. Moreover, recent research indicates that changes in amygdala function may contribute more generally to pathological forms of emotional learning such as drug addiction. Functional magnetic resonance imaging in humans has clearly established the role of the amygdala in emotional processing. Interest in amygdala function has therefore attracted growing interest in both animal and human experiments using both simple behavioural tests and functional imaging. This Conference focuses on research investigating the role of the amygdala in the formation of emotional memories, both normal and pathological.

This year we have included key areas in neurology including topics in secondary stroke prevention and stroke management cases; dementia management and look-alikes; MS treatment, particularly what’s new about the disease and the growing list of medication.

The Gordon Research Conference on the Cerebellum will bring together scientists studying the cerebellum at all levels of analysis, with a goal of fostering dialogue among people engaged in different subfields of cerebellar research. The scientific program has been designed to provide a venue for anatomists, electrophysiologists, developmental biologists, and behavioral neuroscientists, and other researchers with interest in the cerebellum to communicate their latest work to one another. Scientific sessions will cover a wide range of topics, including cerebellar development, human cerebellar function, sensorimotor integration, cerebellar connections to the inferior olive and basal ganglia, emerging technologies to study the cerebellum, cerebellar anatomy, synaptic and circuit mechanisms, and the cerebellum in autism, dystonia, and ataxia. Speakers include senior and junior researchers from all over the world, and the meeting will provide opportunities for scientists of diverse backgrounds and career stages to interact and discuss their hypotheses and discoveries with all other attendees, from leading cerebellar scientists to promising trainees. In addition to the thematic sessions, poster sessions will provide opportunities for attendees to present their work, and a subset of submitted abstracts will be selected to permit graduate students and/or postdoctoral fellows to give short talks. The Conference promises to generate a lively and collegial exchange of ideas, cultivate meaningful collaborations, and ultimately lead to a better understanding of the cerebellum in health and disease.

Inhibitory control of neural circuits is critical to the function of the central nervous system and represents a major target for therapeutics. The 2015 Gordon Research Conference on Inhibition in the CNS will present cutting edge research on molecular, synaptic and circuit-level mechanisms of inhibition, with the goal of facilitating in-depth discussions and collaborations between investigators to advance knowledge in the field. The program will feature prominent investigators that explore fundamental aspects of inhibitory neural function at all levels. Scientific sessions will cover topics including regulation of inhibitory synaptic transmission and plasticity, the role of GABA in developing circuits as well as the development of inhibitory synapses and interneuron diversity, inhibition in intact circuits, and GABAA receptors as drug targets. The meeting will offer a collegial atmosphere with substantial time for interactions among scientists and trainees during the multiple poster sessions and informal gatherings. Some poster presenters will be selected for short talks. The conference promotes opportunities for junior scientists to present research and interact with leaders in the field. The preceding Gordon Research Seminar (GRS) will make this meeting particularly attractive for graduate students and postdoctoral fellows, providing a forum for oral and poster presentations that will prepare junior scientists for the subsequent GRC. The conference promises high-quality and cutting-edge scientific sessions, a lively and collegial exchange of ideas, and a deeper understanding of fundamental mechanisms of inhibition in brain function.

The ASCIP educational conference and expo is a vital resource for Psychologists, Social Workers, Behavioral Health Providers, Physicians, Spinal Cord Injury Nurses, and Occupational and Physical Rehabilitation Therapists with the focus on spinal cord injury and disorder. Professionals attend the ASCIP conference for premium and diverse education, unmatched collaboration, and exposure to the most innovative products and solutions on the market that enrich the continuum of care for individuals with spinal cord injury/disorder.
The 2015 ASCIP Educational Conference will focus on cutting edge and innovative strategies to promote and achieve successful outcomes following SCI/D. It is essential for the professionals working in SCI/D to stay current with recent advances and technology, and this conference will provide a venue to promote optimal quality of life as it relates to SCI/D medicine and rehabilitation.

Neuroscience 2015 is the premier venue for neuroscientists to present emerging science, learn from experts, forge collaborations with peers, explore new tools and technologies, and advance careers. Join more than 30,000 colleagues from more than 80 countries at the world’s largest marketplace of ideas and tools for global neuroscience.

This conference is designed to be one of the leading educational programs available for rehabilitation clinicians across the country. Respected researchers and clinicians provide the most current information on treatment strategies designed to improve patient outcome. It continues to promote improving knowledge about the effects of injury on the brain, the role of brain plasticity in recovery and how treatment interventions influence recovery along with specific neuro sessions to be identified.

Neuroscience 2016 is the premier venue for neuroscientists to present emerging science, learn from experts, forge collaborations with peers, explore new tools and technologies, and advance careers. Join more than 30,000 colleagues from more than 80 countries at the world’s largest marketplace of ideas and tools for global neuroscience.

Neuroscience 2017 is the premier venue for neuroscientists to present emerging science, learn from experts, forge collaborations with peers, explore new tools and technologies, and advance careers. Join more than 30,000 colleagues from more than 80 countries at the world’s largest marketplace of ideas and tools for global neuroscience.

Neuroscience 2018 is the premier venue for neuroscientists to present emerging science, learn from experts, forge collaborations with peers, explore new tools and technologies, and advance careers. Join more than 30,000 colleagues from more than 80 countries at the world’s largest marketplace of ideas and tools for global neuroscience.